INS and metabolic syndrome: Although the exact mechanism is unknown, increased adiposity has been shown to disrupt the hypothalamic–pituitary–ovarian axis and steroidogenic activity in the ovary, through decreased insulin sensitivity, leading to metabolic syndrome and increased inflammation.